Link to fast food availability suggests environment may influence type 1 diabetes rates Hot spots of type 1 diabetes in New York City are found in food swamps, areas with a higher proportion of fast food restaurants, for children and adults with type 1 diabetes, according to a new study published in the Journal of...
Canagliflozin improves renal outcomes in people with type 2 diabetes mellitus (T2DM) with or at high risk for cardiovascular (CV) disease, according to data recently presented at the 2018 National Kidney Foundation’s Spring Clinical Meetings in Austin, Texas.. This benefit was observed in people with both preserved and reduced kidney function, as measured by estimated...
Researchers Suggest Possible Biomarker for Diabetic Cardiomyopathy
Alterations in the myocardial ghrelin-GHSR1a system may predict diabetic cardiomyopathy (DCM), according to a study recently published in the Journal of the Endocrine Society. Researchers led by Savita Dhanvantari, PhD, of the Lawson Health Research Institute in London, Ontario point out that DCM is characterized by progressive cardiac dysfunction, and that the early stages of...
Researchers Report Improved Assessment of the Genetic Risk of Type 1 Diabetes
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type-1 diabetes that is significantly superior to earlier methods. By analyzing up to 41 gene sites, it is possible to identify children at birth who are at least 25-times more likely to develop type...
Ascensia Diabetes Care has revealed the six entries that will progress to the finalist stage of the Ascensia Diabetes Challenge, a global innovation competition that is seeking digital solutions to support type 2 diabetes management. The six finalists were selected from 116 submissions that were received and were chosen by a panel consisting of external...
ENDO 2018: Insulin Pump Known to Be Effective in Adolescents, Adults Also Benefits Children
The MiniMed™ 670G insulin pump system (Medtronic, Northridge, California) can improve glycemic outcomes in children with type 1 diabetes as young as seven years of age, according to an industry-funded study. The results were presented at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill. “The MiniMed™ 670G system can effectively...
The U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Dexcom G6® CGM System. The Dexcom G6 is indicated by the FDA for use as both a standalone CGM and for integration into automated insulin dosing (AID) systems. Along with this authorization, the FDA is establishing criteria, called special controls, which outline...
Researchers have successfully created a novel biomaterial that can be seeded with insulin-producing beta cells. Implantation of the beta cell-seeded biomaterial reversed diabetes in a mouse model by effectively normalizing glucose levels and significantly increasing survival. The research results were presented Monday, March 19, at ENDO 2018, the annual 100th meeting of the Endocrine Society...
Diabetes Research Articles
Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.
